Cingulate
Price & Volume
Stats
See more52W Range | $3.20-$11.89 |
Market Cap | $66.9M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$9.7M |
Diluted EPS | -$4.44 |
News
See moreYahoo Finance • 6 months ago
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
Yahoo Finance • 7 months ago
Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment
Yahoo Finance • 8 months ago
Ascendiant Capital raises Cingulate stock price target to $62 from $61
Yahoo Finance • 8 months ago
Cingulate Inc. Reports Second Quarter 2025 Financial Results and Provides Recent Highlights
About
CEO | Dr. Shane J. Schaffer Pharm.D. |
CFO | Ms. Jennifer L. Callahan CPA |
Address | 1901 West 47th Place, Kansas City, KS, United States, 66205 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |
